Anixa Biosciences Inc - Common Stock (ANIX)

Historical Holders from Q4 2018 to Q3 2025

Symbol
ANIX on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
37,871,761
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
5,413,922
Holdings value
$17,872,434
% of all portfolios
0%
Number of holders
65
Number of buys
24
Number of sells
15
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Anixa Biosciences Inc - Common Stock (ANIX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KUMAR AMIT 16% +8% $16,667,362 +$1,403,336 6,173,097 +9.2% Amit Kumar 04 Jun 2025
As of 30 Sep 2025 Anixa Biosciences Inc - Common Stock (ANIX) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5,413,922 shares of 37,871,761 outstanding shares and own 14% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Anixa Biosciences Inc - Common Stock (ANIX) own 14% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
VANGUARD GROUP INC 3.8% $4,693,729 1,422,342 +2.1%
D.A. DAVIDSON & CO. 1.6% $2,027,098 614,272 0%
Laird Norton Wetherby Trust Company, LLC 1.6% $1,970,876 597,235 -3.2%
UBS Group AG 1.3% $1,565,784 474,480 -6.1%
MISSION WEALTH MANAGEMENT, LP 0.94% $1,175,302 356,152 -3.6%
GEODE CAPITAL MANAGEMENT, LLC 0.91% $1,134,317 343,644 +0.24%
BANK OF AMERICA CORP /DE/ 0.56% $706,051 213,955 +1.7%
BlackRock, Inc. 0.43% $531,372 161,022 +0.97%
STATE STREET CORP 0.32% $397,650 120,500 0%
CITADEL ADVISORS LLC 0.25% $316,833 96,010 +35%
LPL Financial LLC 0.23% $287,117 87,005 +16%
GSA CAPITAL PARTNERS LLP 0.22% $270,000 81,897 +4.9%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.21% $265,277 80,387 +378%
MARSHALL WACE, LLP 0.17% $206,967 62,717 +435%
Bank of New York Mellon Corp 0.15% $192,291 58,270 -0%
NORTHERN TRUST CORP 0.15% $187,968 56,960 -15%
CoreCap Advisors, LLC 0.12% $154,397 46,787 0%
RENAISSANCE TECHNOLOGIES LLC 0.11% $141,121 42,764 +55%
Prosperity Wealth Management, Inc. 0.11% $137,940 41,800 +15%
HighTower Advisors, LLC 0.11% $135,795 41,150 +7.9%
Corient Private Wealth LLC 0.1% $123,420 37,400 0%
Westside Investment Management, Inc. 0.09% $115,500 35,000 0%
Gemmer Asset Management LLC 0.09% $115,500 35,000 0%
Kestra Advisory Services, LLC 0.06% $79,200 24,000 +41%
NATIONS FINANCIAL GROUP INC, /IA/ /ADV 0.06% $74,250 22,500 0%

Institutional Holders of Anixa Biosciences Inc - Common Stock (ANIX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 5,413,922 $17,872,434 +$304,257 $3.30 65
2025 Q2 5,349,048 $17,648,444 -$787,206 $3.30 65
2025 Q1 5,605,891 $16,030,193 -$524,329 $2.86 57
2024 Q4 5,840,981 $13,551,533 +$547,358 $2.32 56
2024 Q3 5,576,916 $17,555,837 +$106,953 $3.15 56
2024 Q2 5,555,557 $12,277,869 +$344,967 $2.21 51
2024 Q1 5,283,801 $16,487,763 +$2,703,700 $3.12 58
2023 Q4 10,080 $39,110 $3.88 1
2023 Q3 3,928,249 $12,844,861 +$921,909 $3.27 49
2023 Q2 3,647,399 $11,674,122 -$399,202 $3.20 45
2023 Q1 3,664,627 $15,755,697 +$369,661 $4.30 44
2022 Q4 3,636,173 $15,451,565 +$552,830 $4.25 49
2022 Q3 3,455,037 $16,993,377 +$1,211,030 $4.92 40
2022 Q2 3,267,227 $9,991,989 -$75,841 $3.06 42
2022 Q1 3,302,911 $9,050,644 -$406,041 $2.74 37
2021 Q4 3,436,723 $10,208,000 +$525,039 $2.97 39
2021 Q3 3,177,493 $15,156,000 +$1,098,637 $4.77 34
2021 Q2 2,951,798 $11,455,000 +$1,488,188 $3.88 31
2021 Q1 1,232,355 $43,605,000 +$38,314,863 $4.68 26
2020 Q4 1,800,328 $5,527,000 +$12,286 $3.07 20
2020 Q3 1,824,831 $4,437,000 +$532,899 $2.43 18
2020 Q2 1,595,826 $4,885,000 +$716,528 $3.06 17
2020 Q1 1,374,864 $2,185,000 +$43,765 $1.59 14
2019 Q4 1,029,278 $3,375,000 -$46,712 $3.28 12
2019 Q3 1,295,952 $5,184,000 +$330,313 $4.00 12
2019 Q2 1,218,355 $4,419,000 -$184,408 $3.63 12
2019 Q1 1,251,395 $5,657,000 +$702,078 $4.52 14
2018 Q4 1,088,361 $4,287,000 +$4,286,976 $3.93 11